hai Aortic stenosis Conferences | Meetings | Events | Symposiums | ConferenceSeries

International Conferences

Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

 

Recommended Conferences for Aortic stenosis

Aortic stenosis


As per available reports about 9 Conference Proceedings, 4 Conferences and 9 relevent journals are published by OMICS International relevant to Aortic stenosis.

Aortic stenosis, is a disease of the heart valves in which the opening of the aortic valve is narrowed. The aortic valve is the valve located between the left ventricle of the heart and the aorta, the largest artery in the body, which carries the entire output of to the systemic circulation. Aortic stenosis is now the most common valvular heart disease in the Western World. Symptoms related to aortic stenosis depend on the degree of valve stenosis. Most people with mild to moderate aortic stenosis are asymptomatic. 

OMICS International organises 1000+ Global Events every year in Conference series, on Clinical, Medicine, Pharma and Science & Technology every year across USA, Europe, Asia, Middle East, Australia and UK with support from 1000 more scientific societies and Publishes 700+ open access journals  which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members.

Scope and Importance

Aortic stenosis is now the most common valvular heart disease in the Western World. Symptoms related to aortic stenosis depend on the degree of valve stenosis. Most people with mild to moderate aortic stenosis are asymptomatic. Symptoms usually present in individuals with severe aortic stenosis, though they may occur in those with mild to moderate aortic stenosis as well. The three cardinal symptoms of aortic stenosis are loss of consciousness, anginal chest pain and shortness of breath with activity or other symptoms of heart failure such as shortness of breath while lying flat, paroxysmal nocturnal dyspnea, or pedal edema.

Angina in the setting of AS is secondary to the left ventricular hypertrophy (LVH) that is caused by the constant production of increased pressure required to overcome the pressure gradient caused by the AS. While the muscular layer of the left ventricle thickens, the arteries that supply the muscle do not get significantly longer or bigger, so the muscle may not receive enough blood supply to meet its requirement for oxygen. This ischemia may first be evident during exercise, when the heart muscle requires increased blood supply to compensate for the increased workload. The individual may complain of anginal chest pain with exertion. At this stage, a cardiac stress test with imaging may be suggestive of ischemia.

It is unclear why aortic stenosis causes syncope. One popular theory is that severe AS produces a nearly fixed cardiac output. When the patient exercises, their peripheral vascular resistance will decrease as the blood vessels of the skeletal muscles dilate to allow the muscles to receive more blood to allow them to do more work. This decrease in peripheral vascular resistance is normally compensated for by an increase in the cardio output. Since patients with severe AS cannot increase their cardiac output, the blood pressure falls and the patient will syncopize due to decreased blood perfusion to the brain. The effect of statins on the progression of AS is still unclear. The latest trials do not show any benefit in slowing AS progression, but did demonstrate a decrease in ischemic cardiovascular events. Angiotensin-converting enzyme (ACE) and angiotensin II receptors have been found in stenotic aortic valves. This leads to the hypothesis that the renin-angiotensin system may play a role in the progression of the disease. To date, there is no randomized trial examining the impact of ACE inhibitors in AS. Innasimuthu et al. showed that patients on bisphosphonates have less progression of aortic stenosis and some regressed. This finding led to multiple trials which is ongoing. Subsequent research has failed to confirm the initial positive result.

Market Analysis

Aortic stenosis is the most common cause of aortic stenosis (AS). While up to 1.5 million people in the U.S. suffer from AS, approximately 500,000 within this group of patients suffer from severe AS. An estimated 250,000 patients with severe AS are symptomatic. An estimated 80,000-85,000 AVR procedures are performed every year in the U.S.

List of Best International Conferences

     6th Cardiology Conference
     November 30-December 02, 2015 San Antonio, USA

     Arrhythmias Conference
     July 14-15, 2016 Brisbane, Australia

     Cardio Vascular Medicine Conference
     April 4-6, 2016 Philadelphia, USA

     Echocardiography Conference
     June 6-7, 2016 London, UK

     7th World Cardiothoracic Conference
     March 29-30, 2016 Atlanta, USA

     Ischemic Heart Diseases Conference
     May 12-13, 2016 Chicago, USA

     Atherosclerosis Conference
     July 11-12, 2016 Philadelphia, USA

     Hypertension & Treatment Conference
     August 04-06, 2016 Toronto, Canada

     10th Interventional Cardiology Conference
     October 20-22, 2016 Rome, Italy

     11th Cardiac Conference
     October 6-8, 2016 Vancouver, Canada

     12th World Cardiology Conference
     October 10-12, 2016 Manchester, UK

     13th European Cardiology Congress
     October 24-26, 2016 Valencia, Spain

     Cardiovascular Imaging Conference
     November 10-12, 2016 Istanbul, Turkey

     Angiology Conference
     December 8-10, 2016 San Antonio, USA

     BIT`s 6th International Congress of Cardiology (ICC-2014)

     2015 American Society of Hypertension (ASH) Annual Scientific Meeting

     CI Meeting 2015 - Innovations in Cardiovascular Interventions

     ACC.15 - The American College of Cardiology 64th Annual Scientific Session & Expo

     7th Annual Stroke and Cerebrovascular Disease Review 2015

     Emergencies in Primary Care 2015

     14th Annual Emergency Radiology Symposium 2014

     18th International Conference on Cardiovascular System and Heart Health

     International Conference for Innovations in Cardiovascular Systems (ICI2015)

     15th Biennial Meeting of the International Society for Applied Cardiovascular Biology

     World Congress of Cardiology & Cardiovascular Health

List of Associations

1. American Heart Association
2. British Cardiac Patients Association
3. Arquivos Brasileiros de Cardiologia
4. British Society of Echocardiography
5. American Society of Echocardiography
6. Canadian Society of Echocardiography
7. Canadian Cardiovascular Society
8. Austin Area Echo Society
9. The Iranian Society of Echocardiography
10. British Heart Foundation
11. Children’s Heart Foundation
12. The German Society of Cardiologists
13. Association for European Paediatric Cardiology
14. German Cardiac Society
15. European Association of Cardiothoracic Anaesthesiologists (EACTA)
16. European Society for Cardio-Vascular Surgery
17. Heart Failure Society of America
18. American Association of Heart Failure Nurses (AAHFN)
19. Association for European Paediatric Cardiology
20. European Heart Rhythm Association

List of Companies
1. Accellent Inc., USA
2. Admedes Schuessler GmbH, Germany
3. AorTech International plc, USA (Multinational)
4. Arbor Surgical Technologies, Inc. USA
5. ATS Medical, Inc. USA
6. AutoTissue GmbH ,Germany
7. Boston Scientific Corporation, USA
8. CarboMedics Inc. Italy (Belgium, Brazil, Canada, China, Dominican Republic, France, Germany, Italy, and the United States.)
9. Cardiac Dimensions Inc. USA, Germany, Australia
10. Cardiosolutions, Inc.,USA
11. Cigna
12. Vasomedical, Inc.
13. Penumbra
14. Sanofi
15. Cardiac Dimensions
16. Abbott
17. Spectranetics
18. ScImage
19. uniQure

This page will be updated regularly.

This page was last updated on November 22, 2024

Conference Series Destinations